Goodwin has received 14 practice rankings and 25 lawyers were named Life Sciences Stars in the 2022 edition of the LMG Life Sciences guide. The annual guide honors law firms and lawyers for outstanding work in life sciences across four main practice areas: Financial and Corporate; Intellectual Property; Non-IP Litigation and Enforcement; and Regulatory.
Notably, Goodwin has been named a U.S. Life Cycle firm by LMG Life Sciences for the eleventh consecutive year. The firm was one of only nine across the country to receive this distinction, which recognizes Goodwin for being ranked in all of the practice areas covered by LMG. The firm also added four new practice rankings this year, further demonstrating how its unparalleled versatility and client-centric approach has resulted in continued growth.
The following Goodwin practice areas were recognized for excellence in LMG Life Sciences:
- Antitrust & Competition
- Corporate
- FDA: Pharmaceutical
- FDA: Medical Device
- General Patent Litigation
- Hatch-Waxman Patent Litigation (Generic)
- Licensing & Collaboration
- Life Cycle
- Mergers & Acquisitions
- Patent Prosecution
- Patent Strategy and Management
- Product Liability
- Venture Capital
- White Collar/Government Investigations
The following Goodwin lawyers were honored as Life Sciences Stars:
- Deborah Birnbach - White Collar/Government Investigations
- Michael Bison - Licensing & Collaboration, Mergers & Acquisitions, Venture Capital
- Elaine Blais - General Patent Litigation
- Mitchell Bloom - Corporate, Licensing & Collaboration, Mergers & Acquisitions, Venture Capital
- Scott Bluni – Patent Prosecution, Patent Strategy & Management
- Kristopher Brown - Corporate, Licensing & Collaboration, Mergers & Acquisitions, Venture Capital
- Stuart Cable - Corporate, Mergers & Acquisitions
- Anthony Downs - General Patent Litigation, Hatch-Waxman Patent Litigation
- Joanne Gray - Product Liability
- Duncan Greenhalgh - Patent Prosecution, Patent Strategy & Management
- William Harrington - White Collar/Government Investigations
- Theresa Kavanaugh - Patent Prosecution, Patent Strategy & Management
- Douglas Kline - General Patent Litigation
- Kirk Ogrosky - White Collar/Government Investigations
- Arman Oruc - Antitrust
- Stephanie Philbin - FDA: Medical Device
- Emily Rapalino – General Patent Litigation, Hatch-Waxman Patent Litigation
- Seo Salimi - Corporate, Mergers & Acquisitions
- Michael Shuster - Patent Prosecution, Patent Strategy & Management
- Sarah Solomon - Licensing & Collaboration, Mergers & Acquisitions
- Kingsley Taft - Corporate, Licensing & Collaboration, Mergers & Acquisitions, Venture Capital
- Julie Tibbets - FDA: Pharmaceutical, FDA: Medical Device
- Daryl Wiesen - General Patent Litigation, Hatch-Waxman Patent Litigation
- Maggie Wong - Corporate, Licensing & Collaboration, Mergers & Acquisitions, Venture Capital
- Sam Zucker - Corporate, Licensing & Collaboration, Mergers & Acquisitions, Venture Capital
LMG’s selection process involved over 1,000 online surveys and interviews with nearly 600 attorneys in the United States, as well as a review of public information and feedback from clients within the industry.
To see Goodwin’s results for 2022, visit LMG Life Sciences.